Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan

Vaccine

Volumn 27, Issue 47, 2009, Pages 6613-6618

  Lu, John Jenn Yenn ^a,d   Cheng, Chi Chia ^b   Chou, Shieu Ming ^a   Hor, Chang Bor ^c   Yang, Yi Chen ^a   Wang, Hsiang Ling ^a  

^a National Taichung Nursing College   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c Taichung Hospital   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adolescents; Anti HBs; Vaccine

Indexed keywords

HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; IMMUNOASSAY; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROPREVALENCE; TAIWAN; VACCINATION; VIRUS IMMUNITY;

ADOLESCENT; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION, SECONDARY; MALE; SEROEPIDEMIOLOGIC STUDIES; STUDENTS; TAIWAN;

EID: 70350574247     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.08.007     Document Type: Article

References (42)

1. Lee W.M. Hepatitis B virus infection. N Engl J Med 337 December (24) (1997) 1733-1745
2. Chen C.J., and Chen D.S. Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology. Hepatology 36 5 (2002) 1046-1049
3. Beasley R.P., Hwang L.Y., Lin C.C., and Chien C.S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2 November (8256) (1981) 1129-1133
4. de Franchis R., Meucci G., Vecchi M., Tatarella M., Colombo M., Del Ninno E., et al. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 118 February (3) (1993) 191-194
5. Beasley R.P., Hwang L.Y., Lin C.C., Leu M.L., Stevens C.E., Szmuness W., et al. Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis 146 2 (1982) 198-204
6. Beasley R.P., Hwang L.Y., Lin C.C., Ko Y.C., and Twu S.J. Incidence of hepatitis among students at a university in Taiwan. Am J Epidemiol 117 2 (1983) 213-222
7. Chen D.S., Sung J.L., and Lai M.Y. A seroepidemiologic study of hepatitis B virus infection in Taiwan. Taiwan Yi Xue Hui Za Zhi 77 12 (1978) 908-918
8. Sung J.L. Hepatitis B virus infection and its sequelae in Taiwan. Gastroenterol Jpn 19 4 (1984) 363-366
9. Chien Y.C., Jan C.F., Kuo H.S., and Chen C.J. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 28 (2006) 126-135
10. Lu S.N., Su W.W., Yang S.S., Chang T.T., Cheng K.S., Wu J.C., et al. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int J Cancer 119 October (8) (2006) 1946-1952
11. Chang M.H., Chen C.J., Lai M.S., Hsu H.M., Wu T.C., Kong M.S., et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 336 June (26) (1997) 1855-1859
12. Chang M.H., Chen T.H., Hsu H.M., Wu T.C., Kong M.S., Liang D.C., et al. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin Cancer Res 11 November (21) (2005) 7953-7957
13. Ni Y.H., Chang M.H., Huang L.M., Chen H.L., Hsu H.Y., Chiu T.Y., et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 135 November (9) (2001) 796-800
14. Lu S.N., Chen C.H., Chen T.M., Lee P.L., Wang J.H., Tung H.D., et al. Hepatitis B virus infection in adolescents in a rural township-15 years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine 24 February (6) (2006) 759-765
15. Su F.H., Chen J.D., Cheng S.H., Sung K.Y., Jeng J.J., and Chu F.Y. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme. J Viral Hepat 15 1 (2008) 14-19
16. Ni Y.H., Huang L.M., Chang M.H., Yen C.J., Lu C.Y., You S.L., et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 132 4 (2007) 1287-1293
17. Su F.H., Chen J.D., Cheng S.H., Lin C.H., Liu Y.H., and Chu F.Y. Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program. J Med Virol 79 2 (2007) 138-143
18. Chang M.H. Hepatitis B virus infection. Semin Fetal Neonatal Med 12 3 (2007) 160-167
19. Chen H.L., Chang C.J., Kong M.S., Huang F.C., Lee H.C., Lin C.C., et al. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology 39 1 (2004) 58-63
20. Chang M.H. Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization. Liver Int 23 5 (2003) 309-314
21. Chan C.Y., Lee S.D., and Lo K.J. Legend of hepatitis B vaccination: the Taiwan experience. J Gastroenterol Hepatol 19 2 (2004) 121-126
22. van der Sande M.A., Waight P., Mendy M., Rayco-Solon P., Hutt P., Fulford T., et al. Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis 193 June (11) (2006) 1528-1535
23. McMahon B.J., Bruden D.L., Petersen K.M., Bulkow L.R., Parkinson A.J., Nainan O., et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 142 March (5) (2005) 333-341
24. Roome A.J., Walsh S.J., Cartter M.L., and Hadler J.L. Hepatitis B vaccine responsiveness in Connecticut public safety personnel. JAMA 270 December (24) (1993) 2931-2934
25. De Silvestri A., Pasi A., Martinetti M., Belloni C., Tinelli C., Rondini G., et al. Family study of non-responsiveness to hepatitis B vaccine confirms the importance of HLA class III C4A locus. Genes Immun 2 7 (2001) 367-372
26. Yu A.S., Cheung R.C., and Keeffe E.B. Hepatitis B vaccines. Clin Liver Dis 8 2 (2004) 283-300
27. Hollinger F.B. Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. Am J Med 87 September (3A) (1989) 36S-40S
28. Chongsrisawat V., Yoocharoen P., Theamboonlers A., Tharmaphornpilas P., Warinsathien P., Sinlaparatsamee S., et al. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health 11 10 (2006) 1496-1502
29. Lin Y.C., Chang M.H., Ni Y.H., Hsu H.Y., and Chen D.S. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis 187 January (1) (2003) 134-138
30. Chen C.C., Yen C.H., Wu W.Y., Hu S.W., Chen S.C., Bell W.R., et al. Epidemiology of hepatitis B virus infection among young adults in Taiwan, China after public vaccination program. Chin Med J (Engl) 120 July (13) (2007) 1155-1158
31. Alfaleh F., Alshehri S., Alansari S., Aljeffri M., Almazrou Y., Shaffi A., et al. Long-term protection of hepatitis B vaccine 18 years after vaccination. J Infect 57 5 (2008) 404-409
32. Chang M.H. Impact of hepatitis B vaccination on hepatitis B disease and nucleic acid testing in high-prevalence populations. J Clin Virol 36 Suppl 1 (2006) S45-50
33. Banatvala J.E., and Van Damme P. Hepatitis B vaccine-do we need boosters?. J Viral Hepat 10 1 (2003) 1-6
34. Milne A., and Waldon J. Recombinant DNA hepatitis B vaccination in teenagers: effect of a booster at 5 1/2 years. J Infect Dis 166 4 (1992) 942
35. Watson B., West D.J., Chilkatowsky A., Piercy S., and Ioli V.A. Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine. Vaccine 19 April (23-24) (2001) 3164-3168
36. Williams I.T., Goldstein S.T., Tufa J., Tauillii S., Margolis H.S., and Mahoney F.J. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination. Pediatr Infect Dis J 22 2 (2003) 157-163
37. Zanetti A.R., Mariano A., Romano L., D'Amelio R., Chironna M., Coppola R.C., et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 366 October (9494) (2005) 1379-1384
38. Petersen K.M., Bulkow L.R., McMahon B.J., Zanis C., Getty M., Peters H., et al. Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis J 23 7 (2004) 650-655
39. Wang L.Y., and Lin H.H. Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago. Vaccine 25 October (41) (2007) 7160-7167
40. Hammitt L.L., Hennessy T.W., Fiore A.E., Zanis C., Hummel K.B., Dunaway E., et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 25 September (39-40) (2007) 6958-6964
41. Zhuang G.H., Yan H., Wang X.L., Hwang L.Y., Wu Q., Wang L.R., et al. Hepatitis B revaccination in healthy non-responder Chinese children: five-year follow-up of immune response and immunologic memory. Vaccine 24 March (12) (2006) 2186-2192
42. Su F.H., Cheng S.H., Li C.Y., Chen J.D., Hsiao C.Y., Chien C.C., et al. Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination. Vaccine 25 November (47) (2007) 8085-8090